Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
biotech
clinical trials
drugs
life sciences
national blog main
the institute for clinical and economic review
akcea therapeutics
alnylam pharmaceuticals
amgen
archive
barry greene
boston
boston blog main
boston top stories
boston university
calcitonin gene-related peptide
chronic migraine
coronavirus
dan ollendorf
eli lilly
episodic migraine
hereditary transthyretin amyloidosis
indiana
indiana blog main
indiana top stories
inotersen
john berk
mary o'donnell
medical
medicine
migraine
national top stories
new york blog main
new york top stories
patisiran
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
What
decision
3
×
fda
announced
agency
ago
alnylam
antiviral
approval
approve
approved
authorization
available
awaits
biological
certain
class
covid
crossed
decades
developed
discovered
drug
eli
fingers
friday
gets
headache
health
here’s
historic
late
lilly
marks
medicine
medicines
migraine
new
noting
oral
pain
Language
unset
Current search:
decision
×
fda
×
@slashgear.com
2 years ago
COVID-19 antiviral pill gets FDA authorization: Here’s the small print
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision